Rhodes Jennifer J
SEC insider (Form 3/4/5 filer). CIK 0001568249. EVP, CHIEF LEGAL OFFICER, SEC at ACADIA PHARMACEUTICALS INC (ACAD). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 25, 2026. Located in SAN DIEGO, CA.
Companies Rhodes Jennifer J has filed insider reports for
- ACADIA PHARMACEUTICALS INC (ACAD): Officer, EVP, CHIEF LEGAL OFFICER, SEC
Rhodes Jennifer J
CIK: 0001568249
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACADIA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 25, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect3.8K shares at avg. $21.47$83K - Mar 24, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect7.5K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
26.4K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
90.7K shares- - Feb 9, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect7K shares at avg. $23.38$162K - Feb 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect12.9K shares- - Mar 24, 2025ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
102.3K shares- - Mar 24, 2025ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
30.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 25, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 3,844 | $21.47 | $82,531 | Direct |
| Mar 24, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 7,515 | - | $0 | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 26,382 | - | - | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 90,691 | - | - | Direct |
| Feb 9, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 6,950 | $23.38 | $162,491 | Direct |
| Feb 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 12,944 | - | $0 | Direct |
| Mar 24, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 102,289 | - | - | Direct |
| Mar 24, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 30,062 | - | - | Direct |
1-8 of 8 transactions